Rankings
▼
Calendar
▼
MREO Q1 2016 Earnings Report — Mereo BioPharma Group plc Revenue & Financial Results | Market Cap Arena
Mereo BioPharma Group plc
MREO
Q1 2016 Earnings
Reported March 30, 2016
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q1 2016
Q4 2015
Q1 2015
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$13M
—
—
—
—
EPS (Diluted)
$-10652.13
—
—
—
—
Free Cash Flow
-$8M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$8M
Selling & Marketing
$0
General & Administrative
$5M
SG&A Expenses
$5M
Other Expenses
$0
Operating Expenses
$12M
Cost & Expenses
$12M
OPERATING INCOME
-$13M
Interest Income
$6.3K
Interest Expense
$0
Other Income/Expenses
$888.9K
INCOME BEFORE TAX
-$12M
Income Tax Expense
-$2M
Net Income from Continuing Ops
-$11M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$11M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$11M
D&A
$12.0K
EBIT
-$13M
EBITDA
-$13M
EPS
-$10.7K
EPS Diluted
-$10.7K
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$11M
Depreciation & Amortization
$12.0K
Stock-Based Compensation
$4M
Deferred Income Tax
$0
Other Non-Cash Items
-$246.5K
Change in Working Capital
-$585.6K
OPERATING CASH FLOW
-$8M
Capital Expenditure
-$954
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
$13.7K
NET CASH FROM INVESTING
$12.8K
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$49M
NET CASH FROM FINANCING
$49M
FREE CASH FLOW
-$8M
Net Change in Cash
$42M
marketcaparena.com
← Q2 2016
MREO Overview